Real-time enrollment status for this metastatic her2-negative breast carcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 10:47 PM UTC
| NCT Number | NCT05770531 |
| Recruiting Status | Recruiting |
| Condition | Metastatic HER2-Negative Breast Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 160 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Vanderbilt-Ingram Cancer Center |
| Last Updated on CT.gov | June 24, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT05770531 is currently recruiting participants. This clinical trial study for metastatic her2-negative breast carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Vanderbilt-Ingram Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05770531 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05770531 was last updated 2 weeks ago (June 24, 2026). HelloStudys verifies this status automatically.